Page last updated: 2024-08-26

mafosfamide and imatinib mesylate

mafosfamide has been researched along with imatinib mesylate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, BS; Champlin, RE; de Lima, M; Decker, WK; Eaves, AC; Eaves, C; Jones, R; Lee, MS; Li, S; McMannis, JD; Ng, J; Niu, T; Robinson, SN; Shpall, EJ; Xing, D; Yang, H; Yao, X	1
Dreger, P; Fruehauf, S; Ho, AD; Jens Zeller, W; Luft, T; Radujkovic, A; Topaly, J	1

Other Studies

2 other study(ies) available for mafosfamide and imatinib mesylate

Article	Year
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone marrow transplantation, 2006, Volume: 37, Issue:6 Topics: Antigens, CD; Antigens, CD34; Antineoplastic Agents; Benzamides; Bone Marrow Purging; Cell Separation; Cell Survival; Cyclophosphamide; Flow Cytometry; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Cells, Circulating; Piperazines; Pyrimidines; Stem Cell Transplantation; Transplantation, Autologous	2006
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia. Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Busulfan; Cell Proliferation; Cyclophosphamide; Drug Interactions; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Transplantation Conditioning; Tumor Cells, Cultured	2014

Article

Year

A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.

Bone marrow transplantation, 2006, Volume: 37, Issue:6

Topics: Antigens, CD; Antigens, CD34; Antineoplastic Agents; Benzamides; Bone Marrow Purging; Cell Separation; Cell Survival; Cyclophosphamide; Flow Cytometry; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Cells, Circulating; Piperazines; Pyrimidines; Stem Cell Transplantation; Transplantation, Autologous

2006

In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia.

Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Busulfan; Cell Proliferation; Cyclophosphamide; Drug Interactions; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Transplantation Conditioning; Tumor Cells, Cultured

2014